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37214 | RSC Adv., 2019, 9, 37214–3722ce metal impurities on Ga-68-
radiolabelling with a tris(3-hydroxy-1,6-
dimethylpyridin-4-one) (THP) chelator†
Ruslan Cusnir,ab Andrew Cakebread,c Margaret S. Cooper,a Jennifer D. Young,a
Philip J. Blower a and Michelle T. Ma *a
GMP-grade 68Ge/68Ga generators provide access to positron-emitting 68Ga, enabling preparation of
Positron Emission Tomography (PET) tracers and PET imaging at sites that do not have access to
cyclotron-produced radionuclides. Radiotracers based on tris(3-hydroxy-1,6-dimethylpyridin-4-one)
(THP) chelators enable simple one-step preparations of 68Ga PET radiopharmaceuticals from pre-
fabricated kits without pre-processing of generator eluate or post-purification. However, trace metal
impurities eluted along with 68Ga could compete for THP and reduce radiochemical yields (RCY). We
have quantified trace metal impurities in 68Ga eluate from an Eckert & Ziegler (E&Z) generator using ICP-
MS. The metals Al, Fe, natGa, Pb, Ti and natZn were present in generator eluate in significantly higher
concentrations than in the starting eluent solution. Concentrations of Fe and natGa in eluate were in the
range of 0.01–0.1 mM, Al, Zn and Pb in the range of 0.1–1 mM, and Ti in the range of 0.9–1.5 mM. To
assess the ability of THP to chelate 68Ga in the presence of such metal ions, radiolabelling reactions
were undertaken in which selected metal ions were added to make them equimolar with THP, or higher.
Al3+, Fe3+, natGa3+ and Ti4+ reduced RCY at concentrations equimolar with THP and higher, but at lower
concentrations they did not affect RCY. Pb2+, Zn2+, Ni2+ and Cr3+ had no effect on RCY (even under
conditions in which each metal ion was present in 100-fold molar excess over THP). The multi-sample
ICP-MS analysis reported here is (to date) the most comprehensive and robust quantification of metal
impurities in the widely used E&Z 68Ga generator. 68Ga from an E&Z generator enables near-quantitative
radiolabelling of THP at chelator concentrations as low as 5 mM (lower than other common gallium
chelators) without pre-processing. The combination of Al3+, Fe3+, natGa3+ and Ti4+ in unprocessed 68Ga
eluate is likely to decrease RCY of 68Ga radiolabelling if a lower amount of THP chelator is used, and
future kit design should take this into account. To increase specific activities by using even lower THP
concentrations, purification of 68Ga from trace metal ions will likely be required.Background
Molecular positron emission tomography (PET) imaging with
radiolabelled receptor-targeted peptides and proteins has been
transformative in management of cancer patients in clinical
centres where it is available.1,2 Gallium-68 (68Ga) is a metallic
radionuclide that emits positrons (t1/2 ¼ 68 min, b+ 90%, Emax
1880 keV) suitable for diagnostic imaging with 68Ga-labelled
chelator-peptide conjugates.3 The short half-life of 68Ga is
compatible with the fast clearance from blood and rapid targetging Sciences, King's College London, St
mail: michelle.ma@kcl.ac.uk
r Institute, 5232 Villigen-PSI, Switzerland
London, Franklin Wilkins Building, 150
tion (ESI) available. See DOI:
1localisation of 68Ga-labelled chelator-peptide conjugates.
However, it also necessitates fast radiolabelling approaches.
One-step, kit-based radiolabelling protocols that provide
a radiopharmaceutical in quantitative radiochemical yield
(RCY), and in pyrogen-free, physiologically-compatible solu-
tions are the ideal for 68Ga radiopharmaceuticals.4,5 Such kit-
based radiosyntheses reduce the need for expensive infra-
structure and highly trained personnel. Kit-based radiosyn-
thesis protocols have been used for formulation of 99mTc
radiopharmaceuticals for almost ve decades. These “one-step”
kits consist of a single pre-fabricated vial that contains all non-
radioactive components and reagents. For simple kit-based
radiosynthesis of 68Ga radiopharmaceuticals to be realised,
the nuclear medicine community needs chelators that bind
68Ga rapidly (<5 min) and quantitatively (RCY > 95%) at low
chelator concentrations (mM range) and near physiological pH
(6–7), preferably avoiding heating or other additional
manipulations.This journal is © The Royal Society of Chemistry 2019
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View Article OnlineDOTA and HBED-CC chelators are used in the radiophar-
maceuticals 68Ga-DOTA-TATE for imaging neuroendocrine
tumours6 and 68Ga-HBED-PSMA for imaging prostate tumours,7
respectively. To date, these chelators have typically required pre-
processing of 68Ga generator eluate to remove competing trace
metal impurities and concentrate 68Ga3+, heating to reproduc-
ibly incorporate 68Ga3+ into the chelator, and post-synthetic
purication to remove unreacted 68Ga3+ and physiologically-
incompatible buffer components.8–10 Hence, they do not meet
the ideal requirements of kit-based radiolabelling.
We have recently developed a THP (tris(3-hydroxy-1,6-
dimethylpyridin-4-one)) chelator (Fig. 1) that rapidly and
quantitatively incorporates 68Ga3+ at room temperature, neutral
pH, and low chelator concentrations, giving a single species.11–13
It is consequently well-suited to kit-based 68Ga-
radiopharmceutical synthesis, unlike other common gallium
chelators such as DOTA and HBED-CC. THP has demonstrated
superior radiolabelling properties compared to many other
chelators, with higher RCYs achievable for THP at very low
concentration compared to e.g. DOTA and HBED.14 THP has
been attached to a number of peptides and proteins that target
cancer cell surface receptors and the conjugates demonstrate
favourable biodistribution and targeting properties in in vivo
PET imaging studies.5,11,15–19 A THP bioconjugate, THP-PSMA,
that targets the prostate specic membrane antigen (PSMA)
has been evaluated recently for one-step kit-based radio-
labelling with 68Ga.5 These resulting GalliProst™ kits can be
radiolabelled in 2–5 min, simply by addition of unprocessed
68Ga generator eluate (typically 5 mL of 0.1 M aqueous HCl
containing 170–270 MBq of 68Ga) to a vial containing THP-
PSMA and sodium bicarbonate buffer.5,16 A new homologue of
THP has been developed with further improved radiolabelling
properties and affinity and selectivity for Ga3+.13
Currently, 68Ga is usually produced from pharmaceutical
grade 68Ge/68Ga generators.20,21 In these generators, the parent
radionuclide 68Ge (t1/2 ¼ 271 days) is adsorbed on a stationary
phase, typically TiO2.
68Ge decay yields 68Ga, which is normally
eluted with an acidic solution (typically aqueous hydrochloric
acid) as 68Ga3+. Frequent elutions and continuous use of acid
can result in leaching of other metal ions from the generator
stationary phase. These can signicantly reduce radiolabellingFig. 1 THP chelator (R ¼ CH3) and its bifunctional chelator derivatives.
This journal is © The Royal Society of Chemistry 2019efficiency due to competition with the radiometal ion for
chelator binding.22 Additionally, the concentration of 68Ga3+ is
very low: 1 GBq of carrier-free 68Ga contains only 9.8 pmol of
68Ga3+, equivalent to approx. 2 nM concentration in 5 mL of
generator eluate. Most chelators do not exclusively bind a single
metal ion, and so both the selectivity of a chelator and the purity
of 68Ga eluate can inuence the RCYs of these reactions. Some
68Ga chelators, such as HBED,23 NOTA24 and TRAP24 have
demonstrated selectivity for Ga3+ over divalent metal ions.
THP ligands were originally developed as iron-sequestering
chelators,25,26 and so as well as having high affinity for Ga3+,
THP also has high affinity for Fe3+, Al3+ and other oxiphilic
transition metal ions.12,13,27–29 The highest molar activity that we
have achieved for a THP conjugate to date is 80MBq nmol1,11,19
equating to <0.1% 68Ga3+ occupancy of THP in these solutions.
This is comparatively low compared to other radiometallated
conjugates – for example, some DTPA- or DOTA-conjugates with
111In can achieve specic activities up to 1 GBq nmol1,30 and
TRAP-conjugates with 68Ga can achieve over 4.8 GBq nmol1,
although the latter is obtained under reaction conditions that
result in <70% RCY.31 It is likely that competition from inter-
fering metal ions in 68Ga generator eluate limits achievement of
higher molar activities for THP.
The objectives of this study were to (i) quantify trace metal
impurities in 68Ga eluate from an Eckert & Ziegler generator and
(ii) evaluate the competition effects of the most common
contaminant metal ions on 68Ga radiolabelling with THP.Methods
Reagents
Sterile ultrapure 0.1 M hydrochloric acid aqueous solution for
elution of 68Ga from 68Ge/68Ga Eckert & Ziegler generator was
supplied by ABX GmbH (Radeberg, Germany). One-year old
generators (yielding 350–450 MBq) were used in this study.
Lead, titanium and zinc standard solutions (1000 mg L1) for
AAS were purchased from VWR. Gallium and nickel standards
for AAS (TraceCERT TM, 1000 mg L1) were purchased from
Sigma-Aldrich. Chromium (as Cr3+) solution for ICP
(1000 mg L1) was purchased from Fisher Chemical.
Aluminium standard for ICP (1000 mg L1) was purchased fromRSC Adv., 2019, 9, 37214–37221 | 37215
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View Article OnlineFluka. Iron AAS standard solution (Specpure®, 1000 mg L1)
was from Alfa Aesar. Sodium chloride ultrapure bioreagent was
obtained from Fisher Scientic. (+)-Sodium L-ascorbate BioXtra
was obtained from Sigma-Aldrich. Hydrochloric acid 20% Pri-
mar for trace metal analysis from Fisher Chemical was used for
conditioning SCX columns. THP was synthesised according to
a previously described procedure.32 Stock solutions of THP in
water (UltraPure™ distilled water from Invitrogen) were stored
at 20 C. Instant thin layer chromatography strips impreg-
nated with silica gel (iTLC-SG) were obtained from Agilent
Technologies and used to determine RCYs. Ethanol and acetone
were of HPLC-grade.
Determination of trace metals in 68Ga generator eluate
68Ga3+ was eluted from an E&Z 68Ge/68Ga generator with ultra-
pure HCl (5 mL, 0.1 M) in a single fraction. Eluates were allowed
to decay for at least 24 h prior to analysis by ICP-MS. Eluent
(ultrapure 0.1 M HCl) was also analysed as a blank. All samples
were stored in polypropylene tubes (Elkay, cat. no. 2086) with
low trace metal content. The concentration of trace metals was
determined on a PerkinElmer NexION 350D inductively coupled
plasma mass spectrometer running Syngistix v1.0 soware
(London Metallomics Facility, King's College London, UK). The
acquisition mode included 5 replicates averaged to give re-
ported values for 27Al, 137Ba, 52Cr, 65Cu, 56Fe, 69Ga, 55Mn, 60Ni,
23Na, 208Pb, 45Sc, 118Sn, 47Ti, 51V, 66Zn and 68Zn. The dwell time
was 50 ms per isotope, with 18 L min1 main argon ow, 1.2
L min1 auxiliary argon ow, 0.97 L min1 nebuliser argon ow
(optimised daily), 1600 W RF power, 0.2 mL min1 sample ow,
and KED cell mode with 4.2 mL min1 helium ow. Concen-
trations of the individual isotopes, 66Zn and 68Zn, were deter-
mined by ICP-MS. natZn was calculated based on natural
abundance of 66Zn (27.9%). 68Zn arising from decay of 68Ga
(decay68Zn) was calculated by subtracting naturally occurring
68Zn (18.75%) from 68Zn determined by ICP-MS.
Competition experiments
To evaluate competition effects of trace metals, THP (5 mM) in
sodium bicarbonate buffer was radiolabelled with 68Ga in the
presence of additional Al3+, Fe3+, natGa3+, Ti4+, Pb2+, Zn2+, Ni2+
and Cr3+ (0.05–500 mM), using the following solutions:
THP solutions. An aliquot of THP solution (54 mM, 28 mL)
was added to an aliquot of sodium bicarbonate solution (66–88
mL, 0.5 M, pH 8.35) to provide 5 mM concentration of chelator in
the nal reaction mixture. As the metal ion standards contained
different amounts of acid, the volume of sodium bicarbonate
(plus a 10% excess) was separately calculated for each radio-
labelling, in order to neutralise 0.1 M HCl (in 68Ga3+ eluate) and
the additional H+ from trace metal stock solutions.
68Ga + added metal ion solutions. 68Ga was eluted from an
E&Z 68Ge/68Ga generator with 5 mL of 0.1 M HCl. An aliquot of
68Ga3+ eluate (2–6 MBq, 70–90 mL) was spiked with a solution
containing a single trace metal (Al, Fe, Ga, Ti, Pb, Zn, Ni and Cr),
to provide concentrations of trace metal ranging from 50 nM to
500 mM (50 nM, 500 nM, 5 mM, 50 mM, and 500 mM) in the nal
reaction mixture.37216 | RSC Adv., 2019, 9, 37214–37221Radiolabelling reactions. The solutions containing 68Ga and
added trace metal ion were added to the THP solutions. The
reaction mixture was made up to 300 mL total volume (using
50–116 mL of 0.1 MHCl), and contained 1.1 mg (1.5 nmol, 5 mM)
of THP. In each reaction solution, the nal pH was 7. The
reaction mixture was vortexed and incubated at room
temperature for 10 min. Each radiolabelling experiment was
replicated three times, with each experiment consisting of 5
technical replicates.
Radiolabelling reactions in the presence of ascorbate.
Aqueous sodium L-ascorbate was added to a solution containing
68Ga3+ and Fe3+, prior to addition of THP. In these reaction
solutions, the nal concentration of ascorbate was 166 mM in
300 mL total volume. The pH and the concentrations of THP,
68Ga3+ and Fe3+ were as described above.
Determining RCY with iTLC. The RCY of [68Ga(THP)] was
determined by iTLC using a mobile phase of 1 M ammonium
acetate in water/methanol (50/50 v/v, pH 5.5). For colloidal and
unreacted 68Ga: Rf < 0.1; for [
68Ga(THP)]: Rf > 0.95. iTLC strips
were imaged and quantied by digital autoradiography using
a Cyclone® Plus phosphor imager and OptiQuant™ soware
(PerkinElmer).Radiolabelling with solutions 68Ga3+ pre-processed using
cation exchange methodologies
Radiolabelling of THP was tested with 68Ga “pre-processed” on
a SCX Bond Elut 100 mg cartridge using methods that use
acidied NaCl,33 ethanol9 or acetone10 solutions to elute the
trapped 68Ga3+ from the cation exchange resin. The amount of
NaHCO3 required to neutralise processed
68Ga was determined
experimentally by titration (in order to account for extra H+
released from the SCX column). Processed eluate (50 mL, 7–19
MBq 68Ga) was added to a solution of THP (5 mM in a nal
volume of 300 mL at pH 7). Aer incubation at RT for 10 min,
RCY was determined by iTLC.Results
Trace metal impurities
Using ICP-MS, we determined the concentrations of common
trace metal impurities (Al, Cr, Cu, Fe, natGa, Mn, Ni, Pb, Sc,
Sn, Ti, V, 66Zn and 68Zn) in 68Ga eluate. The concentrations of
trace metals are known to correlate with the amount of time
between generator elutions.14,22 To probe this, we obtained
generator eluate (5 mL in 0.1 M HCl) either (i) 2 hours aer
a previous generator elution (sample set A), or (ii) 1 day aer
a previous elution (sample set B). These samples were
collected within a period of 20 days, from a generator eluting
330–480 MBq. The mean concentrations of Cr, Cu, Mn, Ni, Sc,
Sn and V were all very low (below 10 nM) in both sample sets A
and B, and in blank eluent solutions of 0.1 M HCl. We have
therefore focused on transition and main group metals Al,
Fe, natGa, Pb, Ti and Zn (Fig. 2). The mean concentrations of
metals Al, Fe, natGa, Pb, Ti and natZn were all higher in sample
sets A and B than in eluent (blank) solution. These concen-
tration differences between eluate and blank solution wereThis journal is © The Royal Society of Chemistry 2019
Fig. 2 Concentrations of selected trace metals in 68Ga generator
eluate measured by ICP-MS. Generator eluate (5 mL in 0.1 M HCl) was
obtained from a single generator either 2 hours after a previous
generator elution (sample set A, red circles, n ¼ 9), or 1 day after
a previous elution (sample set B, purple squares, n ¼ 4). “Blank” eluent
(0.1 M HCl solution from ABX Gmb) was also measured (yellow trian-
gles, n¼ 10). These samples were collected within a period of 20 days,
from a generator eluting 330–480 MBq. Error bars represent standard
deviation of concentrations in the samples.
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View Article Onlinestatistically signicant in all cases (p < 0.1, Table SI-1†), with
the exception of the difference between mean natZn concen-
trations in sample set A and blank solutions.
The metal present at highest concentrations in generator
eluate was Ti. Mean Ti concentration was 1.17  0.37 mM in
sample set A, and 0.95  0.53 mM in sample set B. There was no
signicant difference in mean Ti concentration between sample
sets A and B. The high concentration of Ti in eluate has been
previously observed by us and others: it arises from the solid
phase titanium dioxide material (contained in a borosilicate
glass column) on which 68Ge4+ is immobilised.14,34
The trivalent metal ions Al3+ and Fe3+ bind hydroxypyr-
idinones with high affinities,12,13,27–29 and high concentrations of
Al, Fe and non-radioactive natGa (all likely to be present as
trivalent cations) might therefore be expected to decrease
specic activities of [68Ga(THP)] and its bioconjugates. Al was
present in highest concentration, measuring 0.61  0.47 mM in
sample set A, and 0.91  0.16 mM in sample set B. Al mean
concentrations in blank eluent solutions (0.28  0.05 mM) were
relatively high compared to other metal impurities in blank
eluent solutions. Fe mean concentrations were 0.07  0.05 mM
in sample set A and 0.09  0.02 mM in sample set B. Whilst Al
and Fe mean concentrations were both higher in sample set B
compared with sample set A, neither of these observed differ-
ences were statistically signicant. We observed that increased
time between 68Ga generator elutions resulted in signicantly
increased amounts of non-radioactive natGa in generator eluate.
Mean natGa concentration measured 0.04  0.02 mM in sample
set A, and 0.21  0.12 mM in sample set B (mean difference ¼
0.16 mM, p ¼ 1.4  103).This journal is © The Royal Society of Chemistry 2019Many chelators used for 68Ga radiolabelling, including
DOTA,35 have high affinity for divalent cations such as Zn2+
and Pb2+. Zn impurities arise from the eluent solution,
leaching from generator components and decay of 68Ga. The
presence of Zn (occurring as Zn2+) in generator eluate can
compromise 68Ga radiolabelling of DOTA-based radiophar-
maceuticals.21,36,37 In some clinical 68Ga radiosynthesis proto-
cols, the generator eluate undergoes pre-processing to
separate Zn2+ from 68Ga prior to biomolecule radio-
labelling.10,38 68Ga decays exclusively to 68Zn, and this
contributes to the amount of Zn2+ present in eluate solution.
Factors that directly correlate with the amount of 68Zn in
generator eluate include the activity of the generator, and the
amount of time between elutions of the generator. Here, we
quantied (i) natZn concentration (using 66Zn ICP-MS signal),
and (ii) the amount of 68Zn arising from decay of 68Ga,
“decay68Zn” (using 68Zn ICP-MS signal, and subtracting known
proportions of nat68Zn from this measurement).
Mean natZn concentration measured 0.21  0.13 mM in
sample set A, and 0.30  0.07 mM in sample set B and was
higher in both sample sets compared to blank eluent solution
(0.15  0.16 mM), although this was only statistically signicant
for sample set B (mean difference ¼ 0.15, p ¼ 0.09). Mean
decay68Zn concentration measured 6.1  104  3.4  103 mM
in sample set A (in which samples were collected 2 hours aer
a previous elution), and 2.9  0.7  102 mM in sample set B (in
which samples were collected 1 day aer a previous elution)
(mean difference ¼ 2.8  102, p < 104).
Mean eluate Pb concentrations in both sample set A (0.13 
0.16 mM) and sample set B (0.44  0.56 mM) were higher than
that observed in blank eluent solution (0.03  0.03 mM), and
there was high variability in Pb concentration between indi-
vidual samples in both sample sets A and B. There was no
statistically signicant difference between Pb concentrations in
sample sets A and B. It is likely that Pb content arises from lead
structures used to the shield the generator. Others have also
observed signicant Pb content in generator eluate.34
Changes in Al, Fe, Ga and Ti concentrations in eluate over six
months
To further probe Al, Fe, Ga and Ti concentration in generator
eluate, eluate samples were collected six months apart from
each other, from a second E&Z generator (Fig. 3). These samples
were all obtained 2 hours aer a previous elution. During this
six month period, between our two sample collection
campaigns, the generator was eluted 130 times.
The most remarkable change was observed for mean Ti
breakthrough, which decreased from 1.51  0.09 mM to 0.92 
0.05 mM (mean difference ¼ 0.59 mM, p ¼ 1.8  105) within six
months (Fig. 3 and Table SI-3†). Concentrations of Al and natGa
over this time also decreased. Mean Al concentration decreased
from 0.45  0.13 mM to 0.31  0.05 mM (mean difference ¼ 0.14
mM, p ¼ 6.11  102) and mean natGa concentration decreased
from 0.064  0.022 mM to 0.015  0.018 mM (mean difference ¼
0.049 mM, p ¼ 1.27  102). The mean concentration of Fe also
decreased from 0.077  0.020 to 0.054  0.020 mM, however in
our sample set, this was not statistically signicant.RSC Adv., 2019, 9, 37214–37221 | 37217
Fig. 3 Concentrations of Al, Ti, Fe and natGa in 68Ga eluate as
a function of generator age. Two sets of eluate samples were collected
from the same 68Ga E&Z generator, six months apart from each other.
“Blank” eluent (0.1 M HCl solution from ABX Gmb) used in these two
sets of samples was also measured. During this period, the generator
was eluted 130 times. All eluates were sampled with a pre-elution
window of 2 h. Error bars represent standard deviation of concentra-
tions in the samples.
Fig. 4 Mean RCYs of [68Ga(THP)] in the presence of increasing
concentrations of metal ions ((A): Al3+, Ti4+, Cr3+, Fe3+ and (B): Ni2+,
Zn2+, natGa3+, Pb2+). The vertical dashed line indicates equimolar
concentrations of chelator and metal ion (5 mM), and the horizontal
dashed guide indicates 97% (n ¼ 7) RCY, which is achieved in the
absence of added metal ions. For most values, error bars representing
standard deviation are smaller than the symbols. For a full list of mean
RCY (n ¼ 3) and standard deviation values see Table SI-4.†
RSC Advances Paper
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View Article OnlineThe effect of metal ion impurities in 68Ga radiolabelling
reactions with THP
To identify the effect of the presence of trace/interfering metal
ions on radiolabelling THP with 68Ga, THP was radiolabelled
with 68Ga in a solution containing a spike of each metal ion. We
included the metals identied as being present in generator
eluate at concentrations >10 nM (Al, Fe, natGa, Pb, Ti and natZn),
as well as Ni and Cr, which are present in steel needles oen
used for preparation of radiopharmaceuticals. In these experi-
ments, we used only a small amount of 68Ga eluate (2–6 MBq,
70–90 mL) to minimise the amount of interfering metal ions
from other sources, such as the generator itself. We have also
assumed that the metal ions are present as Al3+, Fe3+, natGa3+,
Pb2+, Ti4+, Zn2+, Ni2+ and Cr3+.
The results of competition experiments with THP and 68Ga3+
in the presence of a single spiked metal ion (at metal ion
concentrations of 50 nM to 500 mM, THP concentrations of 5
mM, pH 7 in carbonate solution) are shown in Fig. 4 and sum-
marised in Table SI-2.† In the absence of a metal ion spike, the
RCY of [68Ga(THP)] was consistently $97%. The presence of
Ni2+, Zn2+, Pb2+ and Cr3+ had no effect on 68Ga radiolabelling
efficiency, even at metal ion concentrations 100-fold greater
than THP concentration.
As expected, the presence of natGa3+ reduced RCY of
[68Ga(THP)] at natGa3+ concentrations$5 mM (to 81 0.78% at 5
mM, 9  0.87% at 50 mM, and 0% at 500 mM), but no signicant
changes were observed at concentrations <5 mM. Similarly, at
concentrations $5 mM, Fe3+, Al3+ and Ti4+ all reduced RCY of
[68Ga(THP)]. At metal ion concentrations equimolar with THP,
RCY of [68Ga(THP)] was 88  3.81% for Fe3+ solutions, 93 
2.30% for Al3+ solutions and 87 2.86% for Ti4+ solutions. At 50
mM metal ion concentrations, RCY of [68Ga(THP)] was 26 
1.25% for Fe3+ solutions, 79 0.47% for Al3+ solutions and 62
1.53% for Ti4+ solutions.37218 | RSC Adv., 2019, 9, 37214–37221Effect of ascorbate on radiolabelling THP in the presence of
Fe3+
In many radiopharmaceutical formulations, ascorbic acid or
sodium ascorbate is included to minimise radiolysis of the
solution. The presence of sodium ascorbate (166 mM, THP
concentrations of 5 mM, and 5–7 MBq 68Ga, pH 7 in bicarbonate
solution) in THP radiolabelling reactions did not reduce radi-
olabelling efficiency of THP with 68Ga (RCY 96  0.4%, n ¼ 6).
Ascorbate can reduce Fe3+ to Fe2+. To assess the practical
implications of this, the RCY of [68Ga(THP)] in reactions con-
taining 68Ga3+, THP, a spike of Fe3+ and ascorbate were
compared with the RCY of reactions containing 68Ga, THP and
a spike of Fe3+ only (Fig. 5). In reactions containing Fe3+ at
concentrations of 5 mM, addition of ascorbate did not affect RCY
of [68Ga(THP)]. In reactions in which Fe3+ was present at
concentrations of 50 or 500 mM, the presence of ascorbate
resulted in increased RCY of [68Ga(THP)]: at [Fe] ¼ 50 mM, RCY
increased from 26  1.25% to 73  4.17%, and at [Fe] ¼ 500 mM
Fe, RCY increased from 2  1.99% to 31  7.29%.This journal is © The Royal Society of Chemistry 2019
Fig. 5 Mean RCYs of [68Ga(THP)] in the presence of either increasing
concentrations of Fe3+ (green triangles) or ascorbate (166 mM) and
increasing concentrations of Fe3+ (n ¼ 5). The vertical dashed line
indicates equimolar concentrations of chelator and metal ion (5 mM),
and the horizontal dashed guide indicates 96 0.4% (n¼ 6) RCY in the
absence of spiked Fe3+. For most values, error bars representing
standard deviation are smaller than the symbols.
Table 1 RCYs for the reaction of THP with unprocessed and pre-
processed 68Ga3+ eluents. Radiolabelling experiments were under-
taken in triplicate
THP, mM RCY  SD (n ¼ 3), %
Unprocessed 68Ga 5.0 96  0.22
0.5 59  3.16
NaCl method 5.0 96  0.58
0.5 70  0.30
Ethanol method 5.0 96  0.35
0.5 58  3.33
Acetone method 5.0 92  3.03
0.5 31  10.26
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View Article OnlineRadiolabelling THP with cation-exchange processed 68Ga
Numerous clinical 68Ga-radiolabelling protocols include eluate
pre-processing steps in which 68Ga is isolated on a cation
exchange cartridge, followed by a washing step and subsequent
elution of 68Ga from the cartridge. These methods concentrate
68Ga and isolate 68Ga from (i) non-radioactive metal ion impu-
rities (such as Fe, Ti and Zn) and (ii) 68Ge that is oen present,
albeit in very low amounts, in generator eluate containing high
concentrations of HCl. There are three well-used methods that
employ solutions of different composition to wash and to
release 68Ga from the cartridge: the “NaCl method”, in which
aqueous 68Ga solutions contain 5 M NaCl and 0.13 M HCl,33,38
the “ethanol method”, in which 68Ga solutions contain 90%
ethanol and 0.9 M HCl,9 and the “acetone method”, in which
68Ga solutions contain 97.6% acetone and 0.05 M HCl.10
The reactivity and speciation of 68Ga in these mixtures with
organic solvents could have effects on radiolabelling efficiency.
To assess the tolerance of THP radiolabelling with pre-
processed 68Ga in the presence of other components in solu-
tion such as NaCl, ethanol and acetone, we reacted THP with
solutions of 68Ga processed according to these three methods.
In these aqueous reaction solutions (nal volume 300 mL) con-
taining pre-processed 68Ga eluate (7–19 MBq, 50 mL, containing
either ethanol, acetone or NaCl eluate solutions), the nal THP
concentration was 5 mM or 0.5 mM, and pH ¼ 7.
We compared the RCY of these reactions with the RCY of
reactions using unprocessed 68Ga (eluate straight from the
generator). At 5 mM THP concentration, the RCY of [68Ga(THP)]
was unaffected by using 68Ga eluent processed using either the
NaCl method or the ethanol method, with RCY >96% (Table 1).
At 0.5 mM THP concentration, the RCY was unaffected for
reactions containing 68Ga eluent processed using the ethanol
method, and slightly improved for reactions containing 68Ga
eluent processed using the NaCl method (Table 1). In contrast,
in reactions containing 68Ga eluent processed using the acetoneThis journal is © The Royal Society of Chemistry 2019method, the RCY of [68Ga(THP)] was signicantly decreased at
both THP concentrations of 5 mM and 0.5 mM.Discussion
Previous studies12,13,27–29 have shown that THP and hydroxypyr-
idinones have particularly high affinity for hard, oxiphilic
cations such as Al3+, Fe3+ and Ga3+, with markedly lower affinity
for divalent metal ions such as Zn2+ and Cu2+. Although THP
has shown remarkably high affinity for Ga3+ (log K1 ¼ 35.0, and
pGa ¼ 30.0 at pH 7.4) and quantitative RCYs when reacted with
68Ga3+ at chelator concentrations as low as 0.5 mM, trace metal
impurities, particularly hard, oxiphilic metal ions, have
a potential to compete with 68Ga3+ for complexation to
THP.12,13,19 For example, for [Fe(THP)], log K1 ¼ 34.2, and pM ¼
29.1 at pH 7.4.13
Our competition experiments showed that the presence of
Al3+, Fe3+, natGa3+ and Ti4+ reduces RCY of [68Ga(THP)] at
concentrations equimolar with THP and higher. Analytical ICP-
MS studies indicate that all of these metals are present in
generator eluate, and that the amounts can vary signicantly
with (i) the time between generator elutions and (ii) the age of
the generator. These ndings have implications for design of
kits that contain THP chelator bioconjugates. At present, the
GalliProst™ kit contains 40 mg of THP-PSMA, and when
reconstituted by simple addition of unprocessed 68Ga generator
eluate, THP-PSMA is at a concentration of 5 mM. Here, the range
of concentrations of Ti (1.17–1.51 mM), Fe (0.07–0.09 mM), natGa
(0.04–0.21 mM) and Al (0.61–0.91 mM) observed in eluate are all
<5 mM. Our experience to date5,16 shows that the presence of
these metals does not affect 68Ga radiolabelling using
GalliProst™ kits. However, if lower amounts/concentrations of
THP bioconjugates were to be used, the combination of Al, Fe,
Ga and Ti in (unprocessed) 68Ga eluate could decrease RCY of
68Ga radiolabelling in such kits.
68Ga radiolabelling of THP is less susceptible to the presence of
some metal ions (Zn2+, Ni2+, Pb2+) compared to DOTA. Prior work
has shown that the presence of a range of metal ions signicantly
decrease RCY of 68Ga-DOTA-based derivatives.22,36,37 For example,
in 68Ga-radiolabelling reactions of DOTA-TATE, a 2 : 1
Pb2+ : DOTA-TATEmolar ratio decreases RCY of 68Ga-DOTA-TATE
to less than 80% (compared to near quantitative RCY in theRSC Adv., 2019, 9, 37214–37221 | 37219
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View Article Onlineabsence of spiked metal ion). For Zn2+, a 6 : 1 ratio decreases RCY
to below 80%. The presence of Zn2+ in 68Ga-radiolabelling reac-
tions of NOTA also decreases RCY of [68Ga(NOTA)].36 Similar to the
case of THP, RCYs of 68Ga-labelled DOTA and NOTA decrease in
the presence of a molar excess of Fe3+ (relative to chelator). In
contrast to THP, RCY of 68Ga-labelled DOTA and NOTA are less
susceptible to the presence of Al3+.36
The multi-sample ICP-MS analysis reported here is (to date)
the most comprehensive and robust quantication of metal ion
impurities in the widely used E&Z 68Ga generator, although we
note that eluates in this study were obtained from 12–18
months old E&Z 68Ga generators. Previous studies have quan-
tied trace metal impurities in 68Ga generator eluate, including
eluate from a Cyclotron Co. Ltd. generator (0.1 M HCl mobile
phase, titanium dioxide solid phase, from Obninsk, Russia),
a generator developed by ANSTO (Australia's Nuclear Science
and Technology Organisation) and single eluate samples from
E&Z 68Ga generators (0.1 M HCl mobile phase, titanium dioxide
solid phase).22,34,39 The amounts of metal ion impurities in our
multi-sample ICP-MS analyses are of a similar magnitude to
previously reported data for eluate deriving from generators
with a titanium dioxide solid phase.14,22,34 Our data on Al, Ti, Fe
and Ga concentrations in eluates obtained six months apart
from each other suggest that the concentration of these metal
ions decreases over time/number of elutions.
We assessed whether the inclusion of other chemical
components, such as ascorbate or organic solvents commonly
used in 68Ga generator eluate pre-processing affect RCY of
[68Ga(THP)]. Addition of ascorbate to 68Ga radiolabelling reac-
tions did not result in decreased RCYs of [68Ga(THP)], and in
this respect, it is a suitable radiolytic stabiliser for radiophar-
maceuticals containing THP chelators. At Fe concentrations of
50 and 500 mM, the presence of ascorbate improved RCY of
[68Ga(THP)], compared to reactions undertaken with a spike of
Fe, but without ascorbate. We attribute this to Fe3+ reduction to
Fe2+. Fe2+ has signicantly lower affinity for hydroxypyridinones
compared to Fe3+. Others' experimental data show that the rate
of ascorbate reduction of Fe3+ to Fe2+ is pH dependent, and can
decrease by an order of magnitude as the pH in aqueous media
increases from 5 to 6.40 Over the timeframe of THP radio-
labelling reactions (<5 min), and at Fe concentrations in
generator eluate (<5 mM), ascorbate reduction of Fe3+ is unlikely
to be of practical importance.
In some radiopharmacies, it has become standard practice
to process 68Ga generator eluate, in order to separate 68Ga from
68Ge breakthrough. The presence of sodium chloride or ethanol
in solutions of processed 68Ga eluate does not adversely affect
RCY of [68Ga(THP)] compared to radiolabelling reactions in
which unprocessed eluate is used, but the use of processed
eluate containing acetone does result in a slight decrease in
RCY and should be avoided in the context of THP-based
radiopharmaceuticals.
Concluding remarks
Metal impurities commonly present in 68Ga generator eluate
can deleteriously affect chelator 68Ga radiolabelling of various
bifunctional chelator-derived radiopharmaceuticals.14,22,36,37 We37220 | RSC Adv., 2019, 9, 37214–37221have provided experimental evidence that 68Ga radiolabelling of
THP is less susceptible to the presence of some of these metal
ions (Zn2+, Cr3+, Ni2+, Pb2+) compared to other clinically used
chelators such as DOTA.
Other metal ions (Fe3+, Ti4+, Al3+, natGa3+) can interfere with
THP radiolabelling if present at sufficient concentration.
However, the low concentrations at which these metals occur in
generator eluate, combined with the amount of THP-based
conjugate currently used in prefabricated kits, results in quan-
titative RCY of these 68Ga–THP conjugates. If lower amounts/
concentrations of THP bioconjugates were used, the combina-
tion of Al3+, Fe3+, natGa3+ and Ti4+ in unprocessed 68Ga eluate
could decrease RCY of 68Ga radiolabelling in such kits, and kit
design should take this into account.Conflicts of interest
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